Press Releases

Disclaimer: Intended for UK medical and trade media only Elafibranor is indicated for the treatment…

Disclaimer: Intended for UK medical and trade media only WREXHAM, UK, 13 June 2023 –…

Disclaimer: Intended for UK medical and trade media only SLOUGH, UK, 5th April 2023 –…

Disclaimer: Intended for UK medical and trade media only Cabozantanib has been recommended by NICE…

Dublin, Ireland, 25th/26th September 2022 Tánaiste joins Ipsen Ireland to launch upgraded manufacturing site in…

Ireland, May 2022 Blanchardstown-based, biopharmaceutical Ipsen has been announced overall Pharma Industry Company of the…

SLOUGH, UK, 21 March 2022 — Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment…

WREXHAM, UK, 24 February 2022 Today, Simon Hart MP, Secretary of State for Wales, visited…

Advanced kidney cancer patients in Scotland become amongst the first in world to access CABOMETYX®▼…